皮膚科処方用治療薬の世界市場 2020年：企業別、地域別、種類・用途別

• 英文タイトル：Global Prescription Dermatology Therapeutics Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：D0804-16439 • 出版社/出版日：GlobalInfoResearch / 2020年7月28日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、109ページ • 納品方法：Eメール • 産業分類：医療

• 販売価格（消費税別）

Single User	￥504,600 (USD3,480)	▷ お問い合わせ
Multi User	￥756,900 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,009,200 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、皮膚科処方用治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。皮膚科処方用治療薬の種類別市場規模（真菌感染症治療薬、皮膚癌治療薬、ニキビ・酒さ治療薬、乾癬治療薬、皮膚炎・脂漏症治療薬）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Pfizer、LEO Pharma、Novartis、AbbVie、Celgene、Johnson & Johnson、Sun Pharmaceutical、Eli Lilly、Amgen、Bausch Health Companies、Aclaris Therapeutics ・地域別グローバル市場分析 2015年-2020年 ・皮膚科処方用治療薬の北米市場（アメリカ、カナダ、メキシコ） ・皮膚科処方用治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・皮膚科処方用治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・皮膚科処方用治療薬の南米市場（ブラジル、アルゼンチン） ・皮膚科処方用治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：真菌感染症治療薬、皮膚癌治療薬、ニキビ・酒さ治療薬、乾癬治療薬、皮膚炎・脂漏症治療薬 ・用途別分析：病院薬局、小売薬局、オンライン薬局 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論

Market Overview
The global Prescription Dermatology Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.2% in the forecast period of 2020 to 2025 and will expected to reach USD 32930 million by 2025, from USD 26930 million in 2019.

The Prescription Dermatology Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Prescription Dermatology Therapeutics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Prescription Dermatology Therapeutics market has been segmented into:
Fungal Infection Drugs
Skin Cancer Drugs
Acne & Rosacea Drugs
Psoriasis Drugs
Dermatitis & Seborrhea Drugs

By Application, Prescription Dermatology Therapeutics has been segmented into:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Prescription Dermatology Therapeutics market presented in the report. This section sheds light on the sales growth of different regional and country-level Prescription Dermatology Therapeutics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Prescription Dermatology Therapeutics market.

The report offers in-depth assessment of the growth and other aspects of the Prescription Dermatology Therapeutics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Prescription Dermatology Therapeutics Market Share Analysis
Prescription Dermatology Therapeutics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Prescription Dermatology Therapeutics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Prescription Dermatology Therapeutics sales, revenue and market share for each player covered in this report.

The major players covered in Prescription Dermatology Therapeutics are:
Pfizer
LEO Pharma
Novartis
AbbVie
Celgene
Johnson & Johnson
Sun Pharmaceutical
Eli Lilly
Amgen
Bausch Health Companies
Aclaris Therapeutics

レポート目次

---

Table of Contents

1 Prescription Dermatology Therapeutics Market Overview
1.1 Product Overview and Scope of Prescription Dermatology Therapeutics
1.2 Classification of Prescription Dermatology Therapeutics by Type
1.2.1 Global Prescription Dermatology Therapeutics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Prescription Dermatology Therapeutics Revenue Market Share by Type in 2019
1.2.3 Fungal Infection Drugs
1.2.4 Skin Cancer Drugs
1.2.5 Acne & Rosacea Drugs
1.2.6 Psoriasis Drugs
1.2.7 Dermatitis & Seborrhea Drugs
1.3 Global Prescription Dermatology Therapeutics Market by Application
1.3.1 Overview: Global Prescription Dermatology Therapeutics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Prescription Dermatology Therapeutics Market by Regions
1.4.1 Global Prescription Dermatology Therapeutics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Prescription Dermatology Therapeutics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Prescription Dermatology Therapeutics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Prescription Dermatology Therapeutics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Prescription Dermatology Therapeutics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Prescription Dermatology Therapeutics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Prescription Dermatology Therapeutics Status and Prospect (2015-2025)
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.2 LEO Pharma
2.2.1 LEO Pharma Details
2.2.2 LEO Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 LEO Pharma SWOT Analysis
2.2.4 LEO Pharma Product and Services
2.2.5 LEO Pharma Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Novartis SWOT Analysis
2.3.4 Novartis Product and Services
2.3.5 Novartis Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.4 AbbVie
2.4.1 AbbVie Details
2.4.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 AbbVie SWOT Analysis
2.4.4 AbbVie Product and Services
2.4.5 AbbVie Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.5 Celgene
2.5.1 Celgene Details
2.5.2 Celgene Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Celgene SWOT Analysis
2.5.4 Celgene Product and Services
2.5.5 Celgene Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Johnson & Johnson SWOT Analysis
2.6.4 Johnson & Johnson Product and Services
2.6.5 Johnson & Johnson Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.7 Sun Pharmaceutical
2.7.1 Sun Pharmaceutical Details
2.7.2 Sun Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Sun Pharmaceutical SWOT Analysis
2.7.4 Sun Pharmaceutical Product and Services
2.7.5 Sun Pharmaceutical Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.8 Eli Lilly
2.8.1 Eli Lilly Details
2.8.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Eli Lilly SWOT Analysis
2.8.4 Eli Lilly Product and Services
2.8.5 Eli Lilly Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.9 Amgen
2.9.1 Amgen Details
2.9.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Amgen SWOT Analysis
2.9.4 Amgen Product and Services
2.9.5 Amgen Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.10 Bausch Health Companies
2.10.1 Bausch Health Companies Details
2.10.2 Bausch Health Companies Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Bausch Health Companies SWOT Analysis
2.10.4 Bausch Health Companies Product and Services
2.10.5 Bausch Health Companies Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.11 Aclaris Therapeutics
2.11.1 Aclaris Therapeutics Details
2.11.2 Aclaris Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Aclaris Therapeutics SWOT Analysis
2.11.4 Aclaris Therapeutics Product and Services
2.11.5 Aclaris Therapeutics Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Prescription Dermatology Therapeutics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Prescription Dermatology Therapeutics Players Market Share
3.2.2 Top 10 Prescription Dermatology Therapeutics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Prescription Dermatology Therapeutics Revenue and Market Share by Regions
4.2 North America Prescription Dermatology Therapeutics Revenue and Growth Rate (2015-2020)
4.3 Europe Prescription Dermatology Therapeutics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Prescription Dermatology Therapeutics Revenue and Growth Rate (2015-2020)
4.5 South America Prescription Dermatology Therapeutics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Prescription Dermatology Therapeutics Revenue and Growth Rate (2015-2020)
5 North America Prescription Dermatology Therapeutics Revenue by Countries
5.1 North America Prescription Dermatology Therapeutics Revenue by Countries (2015-2020)
5.2 USA Prescription Dermatology Therapeutics Revenue and Growth Rate (2015-2020)
5.3 Canada Prescription Dermatology Therapeutics Revenue and Growth Rate (2015-2020)
5.4 Mexico Prescription Dermatology Therapeutics Revenue and Growth Rate (2015-2020)
6 Europe Prescription Dermatology Therapeutics Revenue by Countries
6.1 Europe Prescription Dermatology Therapeutics Revenue by Countries (2015-2020)
6.2 Germany Prescription Dermatology Therapeutics Revenue and Growth Rate (2015-2020)
6.3 UK Prescription Dermatology Therapeutics Revenue and Growth Rate (2015-2020)
6.4 France Prescription Dermatology Therapeutics Revenue and Growth Rate (2015-2020)
6.5 Russia Prescription Dermatology Therapeutics Revenue and Growth Rate (2015-2020)
6.6 Italy Prescription Dermatology Therapeutics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Prescription Dermatology Therapeutics Revenue by Countries
7.1 Asia-Pacific Prescription Dermatology Therapeutics Revenue by Countries (2015-2020)
7.2 China Prescription Dermatology Therapeutics Revenue and Growth Rate (2015-2020)
7.3 Japan Prescription Dermatology Therapeutics Revenue and Growth Rate (2015-2020)
7.4 Korea Prescription Dermatology Therapeutics Revenue and Growth Rate (2015-2020)
7.5 India Prescription Dermatology Therapeutics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Prescription Dermatology Therapeutics Revenue and Growth Rate (2015-2020)
8 South America Prescription Dermatology Therapeutics Revenue by Countries
8.1 South America Prescription Dermatology Therapeutics Revenue by Countries (2015-2020)
8.2 Brazil Prescription Dermatology Therapeutics Revenue and Growth Rate (2015-2020)
8.3 Argentina Prescription Dermatology Therapeutics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Prescription Dermatology Therapeutics by Countries
9.1 Middle East & Africa Prescription Dermatology Therapeutics Revenue by Countries (2015-2020)
9.2 Saudi Arabia Prescription Dermatology Therapeutics Revenue and Growth Rate (2015-2020)
9.3 UAE Prescription Dermatology Therapeutics Revenue and Growth Rate (2015-2020)
9.4 Egypt Prescription Dermatology Therapeutics Revenue and Growth Rate (2015-2020)
9.5 South Africa Prescription Dermatology Therapeutics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Prescription Dermatology Therapeutics Revenue and Market Share by Type (2015-2020)
10.2 Global Prescription Dermatology Therapeutics Market Forecast by Type (2019-2024)
10.3 Fungal Infection Drugs Revenue Growth Rate (2015-2025)
10.4 Skin Cancer Drugs Revenue Growth Rate (2015-2025)
10.5 Acne & Rosacea Drugs Revenue Growth Rate (2015-2025)
10.6 Psoriasis Drugs Revenue Growth Rate (2015-2025)
10.7 Dermatitis & Seborrhea Drugs Revenue Growth Rate (2015-2025)
11 Global Prescription Dermatology Therapeutics Market Segment by Application
11.1 Global Prescription Dermatology Therapeutics Revenue Market Share by Application (2015-2020)
11.2 Prescription Dermatology Therapeutics Market Forecast by Application (2019-2024)
11.3 Hospital Pharmacies Revenue Growth (2015-2020)
11.4 Retail Pharmacies Revenue Growth (2015-2020)
11.5 Online Pharmacies Revenue Growth (2015-2020)
12 Global Prescription Dermatology Therapeutics Market Size Forecast (2021-2025)
12.1 Global Prescription Dermatology Therapeutics Market Size Forecast (2021-2025)
12.2 Global Prescription Dermatology Therapeutics Market Forecast by Regions (2021-2025)
12.3 North America Prescription Dermatology Therapeutics Revenue Market Forecast (2021-2025)
12.4 Europe Prescription Dermatology Therapeutics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Prescription Dermatology Therapeutics Revenue Market Forecast (2021-2025)
12.6 South America Prescription Dermatology Therapeutics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Prescription Dermatology Therapeutics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Prescription Dermatology Therapeutics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Prescription Dermatology Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Prescription Dermatology Therapeutics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Prescription Dermatology Therapeutics Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Pfizer Corporate Information, Location and Competitors
Table 6. Pfizer Prescription Dermatology Therapeutics Major Business
Table 7. Pfizer Prescription Dermatology Therapeutics Total Revenue (USD Million) (2017-2018)
Table 8. Pfizer SWOT Analysis
Table 9. Pfizer Prescription Dermatology Therapeutics Product and Solutions
Table 10. Pfizer Prescription Dermatology Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. LEO Pharma Corporate Information, Location and Competitors
Table 12. LEO Pharma Prescription Dermatology Therapeutics Major Business
Table 13. LEO Pharma Prescription Dermatology Therapeutics Total Revenue (USD Million) (2018-2019)
Table 14. LEO Pharma SWOT Analysis
Table 15. LEO Pharma Prescription Dermatology Therapeutics Product and Solutions
Table 16. LEO Pharma Prescription Dermatology Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Novartis Corporate Information, Location and Competitors
Table 18. Novartis Prescription Dermatology Therapeutics Major Business
Table 19. Novartis Prescription Dermatology Therapeutics Total Revenue (USD Million) (2017-2018)
Table 20. Novartis SWOT Analysis
Table 21. Novartis Prescription Dermatology Therapeutics Product and Solutions
Table 22. Novartis Prescription Dermatology Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. AbbVie Corporate Information, Location and Competitors
Table 24. AbbVie Prescription Dermatology Therapeutics Major Business
Table 25. AbbVie Prescription Dermatology Therapeutics Total Revenue (USD Million) (2017-2018)
Table 26. AbbVie SWOT Analysis
Table 27. AbbVie Prescription Dermatology Therapeutics Product and Solutions
Table 28. AbbVie Prescription Dermatology Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Celgene Corporate Information, Location and Competitors
Table 30. Celgene Prescription Dermatology Therapeutics Major Business
Table 31. Celgene Prescription Dermatology Therapeutics Total Revenue (USD Million) (2017-2018)
Table 32. Celgene SWOT Analysis
Table 33. Celgene Prescription Dermatology Therapeutics Product and Solutions
Table 34. Celgene Prescription Dermatology Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Johnson & Johnson Corporate Information, Location and Competitors
Table 36. Johnson & Johnson Prescription Dermatology Therapeutics Major Business
Table 37. Johnson & Johnson Prescription Dermatology Therapeutics Total Revenue (USD Million) (2017-2018)
Table 38. Johnson & Johnson SWOT Analysis
Table 39. Johnson & Johnson Prescription Dermatology Therapeutics Product and Solutions
Table 40. Johnson & Johnson Prescription Dermatology Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Sun Pharmaceutical Corporate Information, Location and Competitors
Table 42. Sun Pharmaceutical Prescription Dermatology Therapeutics Major Business
Table 43. Sun Pharmaceutical Prescription Dermatology Therapeutics Total Revenue (USD Million) (2017-2018)
Table 44. Sun Pharmaceutical SWOT Analysis
Table 45. Sun Pharmaceutical Prescription Dermatology Therapeutics Product and Solutions
Table 46. Sun Pharmaceutical Prescription Dermatology Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Eli Lilly Corporate Information, Location and Competitors
Table 48. Eli Lilly Prescription Dermatology Therapeutics Major Business
Table 49. Eli Lilly Prescription Dermatology Therapeutics Total Revenue (USD Million) (2017-2018)
Table 50. Eli Lilly SWOT Analysis
Table 51. Eli Lilly Prescription Dermatology Therapeutics Product and Solutions
Table 52. Eli Lilly Prescription Dermatology Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Amgen Corporate Information, Location and Competitors
Table 54. Amgen Prescription Dermatology Therapeutics Major Business
Table 55. Amgen Prescription Dermatology Therapeutics Total Revenue (USD Million) (2017-2018)
Table 56. Amgen SWOT Analysis
Table 57. Amgen Prescription Dermatology Therapeutics Product and Solutions
Table 58. Amgen Prescription Dermatology Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Bausch Health Companies Corporate Information, Location and Competitors
Table 60. Bausch Health Companies Prescription Dermatology Therapeutics Major Business
Table 61. Bausch Health Companies Prescription Dermatology Therapeutics Total Revenue (USD Million) (2017-2018)
Table 62. Bausch Health Companies SWOT Analysis
Table 63. Bausch Health Companies Prescription Dermatology Therapeutics Product and Solutions
Table 64. Bausch Health Companies Prescription Dermatology Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Aclaris Therapeutics Corporate Information, Location and Competitors
Table 66. Aclaris Therapeutics Prescription Dermatology Therapeutics Major Business
Table 67. Aclaris Therapeutics Prescription Dermatology Therapeutics Total Revenue (USD Million) (2017-2018)
Table 68. Aclaris Therapeutics SWOT Analysis
Table 69. Aclaris Therapeutics Prescription Dermatology Therapeutics Product and Solutions
Table 70. Aclaris Therapeutics Prescription Dermatology Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Global Prescription Dermatology Therapeutics Revenue (Million USD) by Players (2015-2020)
Table 72. Global Prescription Dermatology Therapeutics Revenue Share by Players (2015-2020)
Table 73. Global Prescription Dermatology Therapeutics Revenue (Million USD) by Regions (2015-2020)
Table 74. Global Prescription Dermatology Therapeutics Revenue Market Share by Regions (2015-2020)
Table 75. North America Prescription Dermatology Therapeutics Revenue by Countries (2015-2020)
Table 76. North America Prescription Dermatology Therapeutics Revenue Market Share by Countries (2015-2020)
Table 77. Europe Prescription Dermatology Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 78. Asia-Pacific Prescription Dermatology Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 79. South America Prescription Dermatology Therapeutics Revenue by Countries (2015-2020)
Table 80. South America Prescription Dermatology Therapeutics Revenue Market Share by Countries (2015-2020)
Table 81. Middle East and Africa Prescription Dermatology Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 82. Middle East and Africa Prescription Dermatology Therapeutics Revenue Market Share by Countries (2015-2020)
Table 83. Global Prescription Dermatology Therapeutics Revenue (Million USD) by Type (2015-2020)
Table 84. Global Prescription Dermatology Therapeutics Revenue Share by Type (2015-2020)
Table 85. Global Prescription Dermatology Therapeutics Revenue Forecast by Type (2021-2025)
Table 86. Global Prescription Dermatology Therapeutics Revenue by Application (2015-2020)
Table 87. Global Prescription Dermatology Therapeutics Revenue Share by Application (2015-2020)
Table 88. Global Prescription Dermatology Therapeutics Revenue Forecast by Application (2021-2025)
Table 89. Global Prescription Dermatology Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Prescription Dermatology Therapeutics Picture
Figure 2. Global Prescription Dermatology Therapeutics Revenue Market Share by Type in 2019
Figure 3. Fungal Infection Drugs Picture
Figure 4. Skin Cancer Drugs Picture
Figure 5. Acne & Rosacea Drugs Picture
Figure 6. Psoriasis Drugs Picture
Figure 7. Dermatitis & Seborrhea Drugs Picture
Figure 8. Prescription Dermatology Therapeutics Revenue Market Share by Application in 2019
Figure 9. Hospital Pharmacies Picture
Figure 10. Retail Pharmacies Picture
Figure 11. Online Pharmacies Picture
Figure 12. Global Prescription Dermatology Therapeutics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Prescription Dermatology Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Prescription Dermatology Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Prescription Dermatology Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Prescription Dermatology Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Prescription Dermatology Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Prescription Dermatology Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Prescription Dermatology Therapeutics Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Prescription Dermatology Therapeutics Revenue Market Share in 2019
Figure 21. Global Top 10 Players Prescription Dermatology Therapeutics Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Prescription Dermatology Therapeutics Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Prescription Dermatology Therapeutics Revenue Market Share by Regions (2015-2020)
Figure 25. Global Prescription Dermatology Therapeutics Revenue Market Share by Regions in 2018
Figure 26. North America Prescription Dermatology Therapeutics Revenue and Growth Rate (2015-2020)
Figure 27. Europe Prescription Dermatology Therapeutics Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Prescription Dermatology Therapeutics Revenue and Growth Rate (2015-2020)
Figure 29. South America Prescription Dermatology Therapeutics Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Prescription Dermatology Therapeutics Revenue and Growth Rate (2015-2020)
Figure 31. North America Prescription Dermatology Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 32. North America Prescription Dermatology Therapeutics Revenue Market Share by Countries in 2019
Figure 33. USA Prescription Dermatology Therapeutics Revenue and Growth Rate (2015-2020)
Figure 34. Canada Prescription Dermatology Therapeutics Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Prescription Dermatology Therapeutics Revenue and Growth Rate (2015-2020)
Figure 36. Europe Prescription Dermatology Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Prescription Dermatology Therapeutics Revenue Market Share by Countries in 2019
Figure 38. Germany Prescription Dermatology Therapeutics Revenue and Growth Rate (2015-2020)
Figure 39. UK Prescription Dermatology Therapeutics Revenue and Growth Rate (2015-2020)
Figure 40. France Prescription Dermatology Therapeutics Revenue and Growth Rate (2015-2020)
Figure 41. Russia Prescription Dermatology Therapeutics Revenue and Growth Rate (2015-2020)
Figure 42. Italy Prescription Dermatology Therapeutics Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Prescription Dermatology Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Prescription Dermatology Therapeutics Revenue Market Share by Countries in 2019
Figure 45. China Prescription Dermatology Therapeutics Revenue and Growth Rate (2015-2020)
Figure 46. Japan Prescription Dermatology Therapeutics Revenue and Growth Rate (2015-2020)
Figure 47. Korea Prescription Dermatology Therapeutics Revenue and Growth Rate (2015-2020)
Figure 48. India Prescription Dermatology Therapeutics Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Prescription Dermatology Therapeutics Revenue and Growth Rate (2015-2020)
Figure 50. South America Prescription Dermatology Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 51. South America Prescription Dermatology Therapeutics Revenue Market Share by Countries in 2019
Figure 52. Brazil Prescription Dermatology Therapeutics Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Prescription Dermatology Therapeutics Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Prescription Dermatology Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Prescription Dermatology Therapeutics Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Prescription Dermatology Therapeutics Revenue and Growth Rate (2015-2020)
Figure 57. UAE Prescription Dermatology Therapeutics Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Prescription Dermatology Therapeutics Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Prescription Dermatology Therapeutics Revenue and Growth Rate (2015-2020)
Figure 60. Global Prescription Dermatology Therapeutics Revenue Share by Type (2015-2020)
Figure 61. Global Prescription Dermatology Therapeutics Revenue Share by Type in 2019
Figure 62. Global Prescription Dermatology Therapeutics Market Share Forecast by Type (2021-2025)
Figure 63. Global Fungal Infection Drugs Revenue Growth Rate (2015-2020)
Figure 64. Global Skin Cancer Drugs Revenue Growth Rate (2015-2020)
Figure 65. Global Acne & Rosacea Drugs Revenue Growth Rate (2015-2020)
Figure 66. Global Psoriasis Drugs Revenue Growth Rate (2015-2020)
Figure 67. Global Dermatitis & Seborrhea Drugs Revenue Growth Rate (2015-2020)
Figure 68. Global Prescription Dermatology Therapeutics Revenue Share by Application (2015-2020)
Figure 69. Global Prescription Dermatology Therapeutics Revenue Share by Application in 2019
Figure 70. Global Prescription Dermatology Therapeutics Market Share Forecast by Application (2021-2025)
Figure 71. Global Hospital Pharmacies Revenue Growth Rate (2015-2020)
Figure 72. Global Retail Pharmacies Revenue Growth Rate (2015-2020)
Figure 73. Global Online Pharmacies Revenue Growth Rate (2015-2020)
Figure 74. Global Prescription Dermatology Therapeutics Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Prescription Dermatology Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Prescription Dermatology Therapeutics Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Prescription Dermatology Therapeutics Revenue Market Forecast (2021-2025)
Figure 78. Europe Prescription Dermatology Therapeutics Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Prescription Dermatology Therapeutics Revenue Market Forecast (2021-2025)
Figure 80. South America Prescription Dermatology Therapeutics Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Prescription Dermatology Therapeutics Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel

---